Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities - 26/01/14
Doi : 10.1016/j.jaci.2013.11.039
Jonathan J. Lyons, MD a, Guangping Sun, MD a, Kelly D. Stone, MD, PhD a, Celeste Nelson, CRNP a, Laura Wisch, MSN a, Michelle O'Brien, RN, BSN a, Nina Jones, RN, BSN b, Andrew Lindsley, MD, PhD c, Hirsh D. Komarow, MD a, Yun Bai, MS a, Linda M. Scott, MS, CRNP a, Daly Cantave, MSN d, Irina Maric, MD e, J. Pablo Abonia, MD c, Marc E. Rothenberg, MD, PhD c, Lawrence B. Schwartz, MD, PhD f, Joshua D. Milner, MD a 
, Todd M. Wilson, DO a
, Todd M. Wilson, DO a a Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md
b Clinical Research Directorate/CMRP, Leidos Biomedical Research (formerly SAIC-Frederick), Frederick National Laboratory for Cancer Research, Frederick, Md
c Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
d Clinical Center, National Institutes of Health, Bethesda, Md
e Department of Laboratory Medicine, National Institutes of Health, Bethesda, Md
f Department of Internal Medicine, Virginia Commonwealth University, Richmond, Va
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Sunday 26 January 2014
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
| Supported by National Institutes of Health (NIH) U19AI77435, and in part by grants from Food Allergy Research and Education (formerly the Food Allergy and Anaphylaxis Network [FAAN], the Food Allergy Project [FAP], and the Food Allergy Initiative [FAI]), the Buckeye Foundation, and the Campaign Urging Research for Eosinophilic Diseases (CURED) Foundation. This project has been funded in part with federal funds from the National Cancer Institute, NIH, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the NIAID. |
|
| Disclosure of potential conflict of interest: N. Jones has received a grant from LEIDOS. J. P. Abonia has received grants from the National Institutes of Health (NIH), Food Allergy Research and Education (FARE), the Food Allergy & Anaphylaxis Network, the Buckeye Foundation, and the Campaign Urging Research for Eosinophilic Diseases Foundation. M. E. Rothenberg has received research support from the NIH, the CURED Foundation, FARE, and the Buckeye Foundation; is a board member of the International Eosinophil Society Steering Committee and the APFED Medical Panel; has consultant arrangements with Immune Pharmaceuticals, Pluristem Pharmaceuticals, Receptos, and Novartis; is an inventor on patents submitted and owned by Cincinnati Children's Hospital Medical Center; receives royalties from Teva Pharmaceuticals; and has stock/stock options in Immune Pharmaceuticals and Receptos. L. B. Schwartz is on the board of directors for the Clinical Immunology Society and the Asthma and Allergy Foundation of America; has consultant arrangements with Sanofi Aventis, Dyax, and Viropharma; has received grants from CSL Behring and Dyax; receives royalties for licensing arrangements through VCU Tech Transfer; and receives honorarium as Associate Editor of the Journal of Clinical Immunology. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?